Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 1/20 | 0.47 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 2/20 | 0.42 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.42 |
| ▸ | GRIA3 | P42263 | 2/20 | 0.42 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.42 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.42 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.42 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.42 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.42 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.42 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.42 |
| ▸ | GRIK4 | Q16099 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5924163 | 0.81 | RAB9A (0.45) | F10CYP3A4 | |
| SCHEMBL4479696 | 0.81 | HRH4 (0.54) | F10 | |
| SCHEMBL5924458 | 0.81 | TUBB4A (0.56) | F10CYP3A4ABL1 | |
| Hydrochloric Acid SCHEMBL11786459 | 0.80 | RAB9A (0.44) | F10CYP3A4 | |
| SCHEMBL16480441 | 0.77 | LMNA (0.58) | CACNA1GGAAHTTGRIN2DGRIN3B | |
| SCHEMBL2946951 | 0.75 | RAB9A (0.45) | F10HTTLMNACYP3A4 | |
| SCHEMBL29609514 | 0.75 | TUBB4A (0.58) | F10GAAHTTLMNAABL1 | |
| SCHEMBL5924182 | 0.75 | HTT (0.49) | F10GAAHTTLMNAEGLN1 | |
| SCHEMBL4686558 | 0.75 | MEN1 (0.52) | F10HTTLMNACYP3A4ABL1 | |
| SCHEMBL6988665 | 0.75 | MTOR (0.47) | F10GAALMNACYP3A4ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366557-A1 | ORAL HEALTH COMPOSITION COMPRISING PURIFIED BIOSURFACTANTS AND/OR THEIR DERIVATIVES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2024-11-07 | — | — | US | disclosed |
| US-20240269057-A1 | Oral Health Composition Comprising Purified Biosurfactants and/or Their Derivatives | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2024-08-15 | — | — | US | disclosed |
| US-11964040-B2 | Oral health composition comprising purified biosurfactants and/or their derivatives | LOCUS SOLUTIONS IPCO, LLC (US) | 2024-04-23 | — | — | US | disclosed |
| WO-2023196764-A1 | ORAL HEALTH COMPOSITION COMPRISING PURIFIED BIOSURFACTANTS AND/OR THEIR DERIVATIVES | LOCUS SOLUTIONS IPCO, LLC (US) | 2023-10-12 | — | — | WO | disclosed |
| US-20200345610-A1 | Oral Health Composition Comprising Purified Biosurfactants and/or Their Derivatives | LOCUS CONSUMER BRANDS HOLDING, LLC | 2020-11-05 | — | — | US | disclosed |
| EP-3731804-A1 | ORAL HEALTH COMPOSITION COMPRISING PURIFIED BIOSURFACTANTS AND/OR THEIR DERIVATIVES | Locus IP Company, LLC (US) | 2020-11-04 | — | — | EP | disclosed |
| US-8450294-B2 | Shampoo compositions | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2013-05-28 | — | — | US | disclosed |
| US-20090318571-A1 | Hydrocolloids and Process Therefor | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2009-12-24 | — | — | US | disclosed |
| EP-1841402-B9 | PROCESS FOR PREPARING HYDROCOLLOIDS | LUBRIZOL ADVANCED MAT INC (US) | 2009-09-16 | — | — | EP | disclosed |
| US-20090137438-A1 | Hydrocolloids and Process Therefor | LUBRIZOL ADVANCED MATERIALS, INC. | 2009-05-28 | — | — | US | disclosed |
| US-3941877-A | A MONOFLUOROPHOSPHATE, CALCIUM CARBONATE, ALKALI METAL METAPHOSPHATE | COLGATE-PALMOLIVE COMPANY (US) | 1976-03-02 | — | — | US | disclosed |
| US-3939261-A | DIPEPTIDE SWEETENER, ACID ANHYDRIDE | COLGATE-PALMOLIVE COMPANY (US) | 1976-02-17 | — | — | US | disclosed |
| US-3937804-A | TOOTHPASTE | COLGATE-PALMOLIVE COMPANY (US) | 1976-02-10 | — | — | US | disclosed |
| US-3937803-A | FLAVORED DENTAL CREAMS | COLGATE-PALMOLIVE COMPANY (US) | 1976-02-10 | — | — | US | disclosed |
| US-3937321-A | Toothpaste | COLGATE-PALMOLIVE COMPANY (US) | 1976-02-10 | — | — | US | disclosed |
| US-3937805-A | METHOD OF MAKING DENTIFRICE COMPOSITIONS CONTAINING INSOLUBILIZED SALTS OF 1,6-DI-(P-CHLOROPHENYL BIGUANIDO) HEXANE | COLGATE-PALMOLIVE COMPANY (US) | 1976-02-10 | — | — | US | disclosed |
| US-3935304-A | Dental creams | COLGATE-PALMOLIVE COMPANY (US) | 1976-01-27 | — | — | US | disclosed |
| US-3935305-A | SODIUM BICARBONATE, ABRASIVE, POLYOL HUMECTANT | COLGATE-PALMOLIVE COMPANY (US) | 1976-01-27 | — | — | US | disclosed |
| US-3934000-A | SODIUM CARBOXYMETHYL CELLULOSE, POLYOXYETHYLENE GLYCOL, SILICA, ABRASIVE | COLGATE-PALMOLIVE COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
| US-3932606-A | SWEETENERS, 3,4-DIHYDRO-1,2,3-OXATHIAZIN-4- ONE | COLGATE-PALMOLIVE COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366557-A1 | ORAL HEALTH COMPOSITION COMPRISING PURIFIED BIOSURFACTANTS AND/OR THEIR DERIVATIVES | DDOST, CCL11, MGLL | F10 2761/4885CACNA1G 4689/4885GAA 1996/4885 |
| US-20090137438-A1 | Hydrocolloids and Process Therefor | ALG1, GYPA, HSD17B7 | F10 2930/4885CACNA1G 4771/4885GAA 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.